Patent AnalyticsExaminers
Rankings

Law firm or agent

Baker Donelson (Adimab)

25 applicationsfiled 2016 to 2026

Allowance rate
73%
−2 pts vs the USPTO range 48% to 89%
Rejections before allowance
1.6
level with the USPTO
Months to first action
28.3 mo
+9.7 vs the USPTO
Needed an RCE
25%
−2 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07K Peptides23 apps
A61P Therapeutic activity of compounds1 apps

Art units

16446 apps
16416 apps
OPAP5 apps
16433 apps
16482 apps
16421 apps

Who they file for

Clients with the most applications

ADIMAB, LLC25 apps
73%

Bars show the share of decided applications that were allowed.

Unlock the clients they file forIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19447385HIGH AFFINITY ANTI-CD3 ANTIBODIES, AND METHODS FOR THEIR GENERATION AND USE2026-01-13Pending00n/a
19484392ANTI-CD28 ANTIBODIES AND METHODS RELATED THERETO2025-11-14Pending00n/a
19122279PH-DEPENDENT ANTI-CD3 ANTIBODIES AND METHODS RELATING THERETO2025-04-18Pending00n/a
15319967Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15645929Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15436021Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15363946Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15453647Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15214148Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15438806Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 25 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in